Get the Stockscreener App
2.52
7.01%
-0.19
After Hours:
2.64
0.12
+4.76%
Moleculin Biotech Inc Stock (MBRX) Forecast
The Moleculin Biotech Inc (MBRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.8642, representing a +53.34% increase from the current price of $2.52. The highest analyst price target is $4.1912, and the lowest is $3.5373.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MBRX Price Target
Average 4.6876
(+86.02% Upside)
Is Moleculin Biotech Inc (MBRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.97 | Neutral |
| STOCH(9,6) | 54.80 | Neutral |
| STOCHRSI(14) | 34.49 | Neutral |
| MACD(12,26) | 0.0388 | Buy |
| ADX(14) | 20.16 | Neutral |
| William %R | -77.88 | Neutral |
| CCI(14) | 35.13 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.561
Sell
|
2.6098
Sell
|
| MA20 |
2.5553
Sell
|
2.5694
Sell
|
| MA50 |
2.5184
Buy
|
2.6001
Sell
|
| MA100 |
2.7637
Sell
|
3.0204
Sell
|
| MA200 |
4.3276
Sell
|
4.1838
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, MBRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 9 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on MBRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 48.97 indicates that MBRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 54.8 indicates that MBRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 34.49 indicates that MBRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.16 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 35.13 indicates that MBRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term MBRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Moleculin Biotech Inc financial reports and earnings history, Moleculin Biotech Inc (MBRX) stock could reach $2.5661 by 2030, $4.9462 by 2040 and $9.2319 by 2050. See the projected annual prices until 2050 of the Moleculin Biotech Inc stock below:
- Moleculin Biotech Inc (MBRX) is expected to reach an average price of $3.0616 in 2035, with a high prediction of $3.1371 and a low estimate of $3.0987. This indicates an $21.49% rise from the last recorded price of $2.52.
- Moleculin Biotech Inc (MBRX) stock is projected to chart a bullish course in 2040, with an average price target of $4.9968, representing an $98.28% surge from its current level. The forecast ranges from a conservative $4.8975 to a sky-high $4.9462.
- Our analysts predict Moleculin Biotech Inc (MBRX) to jump 176.99% by 2045, soaring from $6.8165 to an average price of $6.98, potentially reaching $6.90. While $6.8165 is the low estimate, the potential upside is significant.
- Moleculin Biotech Inc (MBRX) stock is expected to climb by 2050, reaching an average of $9.0967, a $260.98% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.2319 and $9.2623, respectively, highlighting the market's uncertainty.
Moleculin Biotech Inc Stock (MBRX) Year by Year Forecast
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2024
Our forecast for MBRX stock price in 2024 now indicates an average price target of $3.39 with a high forecast of $6.38 and a low forecast of $0.40. The average prediction reflects an increase of +34.52% from the last recorded price of $2.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $3.6003 | $3.5373 | $4.1912 | +42.87% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2025
Moleculin Biotech Inc Stock (MBRX) is expected to reach an average price of $4.6876 in 2025, with a high prediction of $9.3611 and a low estimate of $0.0141. This indicates an +86.02% rise from the last recorded price of $2.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.0215 | $2.5925 | $3.7234 | +19.90% |
| February, 2025 | $2.7277 | $2.6077 | $3.3216 | +8.24% |
| March, 2025 | $1.5458 | $1.1258 | $4.8307 | -38.66% |
| April, 2025 | $1.195 | $0.0141 | $2.389 | -52.58% |
| May, 2025 | $4.3872 | $0.6791 | $9.3611 | +74.10% |
| June, 2025 | $3.9794 | $3.7333 | $4.8102 | +57.91% |
| July, 2025 | $3.5746 | $3.0374 | $4.8915 | +41.85% |
| August, 2025 | $2.7209 | $2.4599 | $3.8716 | +7.97% |
| September, 2025 | $4.0789 | $2.2698 | $6.8928 | +61.86% |
| October, 2025 | $2.2215 | $1.9341 | $4.2619 | -11.85% |
| November, 2025 | $2.5025 | $1.9371 | $3.0263 | -0.70% |
| December, 2025 | $1.7869 | $1.7215 | $2.9723 | -29.09% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2026
The predicted value for Moleculin Biotech Inc (MBRX) in 2026 is set at an average of $3.4727. Estimates vary from a peak of $6.4671 to a trough of $0.4783, indicating an +37.80% surge from the present price of $2.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.2976 | $1.5601 | $2.7506 | -8.82% |
| February, 2026 | $2.5462 | $2.1195 | $4.9797 | +1.04% |
| March, 2026 | $3.4979 | $2.3044 | $4.2179 | +38.81% |
| April, 2026 | $2.6231 | $2.0371 | $6.4671 | +4.09% |
| May, 2026 | $1.8353 | $0.8593 | $2.6612 | -27.17% |
| June, 2026 | $1.5075 | $1.3714 | $2.4814 | -40.18% |
| July, 2026 | $1.0327 | $0.8435 | $1.6905 | -59.02% |
| August, 2026 | $1.6048 | $1.0257 | $1.7348 | -36.32% |
| September, 2026 | $1.32 | $1.08 | $1.6779 | -47.62% |
| October, 2026 | $0.8622 | $0.7822 | $1.5031 | -65.79% |
| November, 2026 | $0.8643 | $0.4783 | $0.9452 | -65.70% |
| December, 2026 | $0.7995 | $0.5965 | $0.9874 | -68.27% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Moleculin Biotech Inc (MBRX) is $0.4255, with a high forecast of $0.8248 and a low forecast of $0.0261. This indicates an -83.12% decrease from the last price of $2.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.5417 | $0.4156 | $0.8248 | -78.50% |
| February, 2027 | $0.0239 | $0.0261 | $0.5647 | -99.05% |
| March, 2027 | $0.0209 | $0.1309 | $0.166 | -99.17% |
| April, 2027 | $0.4388 | $0.1529 | $0.3188 | -82.59% |
| May, 2027 | $0.6466 | $0.6352 | $0.6097 | -74.34% |
| June, 2027 | $0.8014 | $0.6736 | $0.7145 | -68.20% |
| July, 2027 | $0.3293 | $0.4493 | $0.7584 | -86.93% |
| August, 2027 | $0.2771 | $0.2932 | $0.2562 | -89.00% |
| September, 2027 | $0.5719 | $0.5441 | $0.6949 | -77.31% |
| October, 2027 | $0.5797 | $0.6445 | $0.5797 | -76.99% |
| November, 2027 | $0.3676 | $0.6336 | $0.5667 | -85.41% |
| December, 2027 | $0.4224 | $0.3615 | $0.3113 | -83.24% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2028
In 2028, Moleculin Biotech Inc (MBRX) is projected to reach an average price of $0.8431, with a high projection of $1.2868 and a low estimate of $0.3993. This indicates an -66.55% fall from the last price of $2.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6002 | $0.3993 | $0.4902 | -76.18% |
| February, 2028 | $0.9581 | $0.6872 | $0.8081 | -61.98% |
| March, 2028 | $1.0029 | $0.965 | $1.0161 | -60.20% |
| April, 2028 | $0.7007 | $0.8807 | $1.0248 | -72.19% |
| May, 2028 | $0.7655 | $0.6745 | $0.6455 | -69.62% |
| June, 2028 | $0.6833 | $0.7385 | $0.7424 | -72.88% |
| July, 2028 | $0.7794 | $0.7403 | $0.6642 | -69.07% |
| August, 2028 | $0.896 | $0.7351 | $0.689 | -64.45% |
| September, 2028 | $1.0038 | $0.9929 | $0.9638 | -60.17% |
| October, 2028 | $1.1117 | $1.0608 | $1.1168 | -55.88% |
| November, 2028 | $1.2872 | $1.3152 | $1.2581 | -48.92% |
| December, 2028 | $1.3055 | $1.3234 | $1.2868 | -48.20% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2029
The 2029 price forecast for Moleculin Biotech Inc Stock (MBRX) is $2.7775 on average, with a high prediction of $4.4895 and a low estimate of $1.0655. This represents an +10.22% increase from the previous price of $2.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.2359 | $1.2291 | $1.2837 | -50.96% |
| February, 2029 | $1.2949 | $1.266 | $1.2579 | -48.61% |
| March, 2029 | $1.4478 | $1.2993 | $1.3948 | -42.55% |
| April, 2029 | $1.3826 | $1.4296 | $1.4117 | -45.13% |
| May, 2029 | $1.2774 | $1.3249 | $1.3136 | -49.31% |
| June, 2029 | $1.1952 | $1.2252 | $1.201 | -52.57% |
| July, 2029 | $0.9347 | $1.1731 | $1.1922 | -62.91% |
| August, 2029 | $1.2739 | $1.0655 | $1.2479 | -49.45% |
| September, 2029 | $1.2259 | $1.2858 | $1.255 | -51.35% |
| October, 2029 | $3.9542 | $1.1554 | $4.4895 | +56.91% |
| November, 2029 | $2.9116 | $2.5416 | $4.4873 | +15.54% |
| December, 2029 | $2.44 | $2.14 | $3.76 | -3.17% |
Moleculin Biotech Inc Stock (MBRX) Price Forecast for 2030
Moleculin Biotech Inc Stock (MBRX) is expected to reach an average price of $1.5207 in 2030, with a high forecast of $2.9565 and a low forecast of $0.085. This signifies an -39.65% decrease from the last price of $2.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.6904 | $1.0782 | $2.5661 | -32.92% |
| February, 2030 | $2.4947 | $1.6365 | $2.9565 | -1.00% |
| March, 2030 | $1.199 | $1.019 | $2.7408 | -52.42% |
| April, 2030 | $1.6434 | $0.9051 | $2.0573 | -34.79% |
| May, 2030 | $1.5538 | $1.3494 | $2.6216 | -38.34% |
| June, 2030 | $1.6981 | $0.9598 | $1.8181 | -32.62% |
| July, 2030 | $1.3685 | $1.0624 | $1.8422 | -45.69% |
| August, 2030 | $1.0328 | $0.6728 | $1.5546 | -59.02% |
| September, 2030 | $0.6071 | $0.085 | $1.1589 | -75.91% |
| October, 2030 | $0.4125 | $0.1154 | $2.3415 | -83.63% |
| November, 2030 | $2.2901 | $0.4664 | $1.0481 | -9.12% |
| December, 2030 | $1.5038 | $1.6238 | $1.3238 | -40.32% |
3.66%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):